Denosumab Protective Against Diabetes?
(MedPage Today) -- Continued treatment with the osteoporosis drug denosumab (Prolia) was tied to a lower risk of developing diabetes in a Taiwanese cohort study.
In a propensity score-matched analysis, adherence to denosumab for osteoporosis was...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Orthopaedics | Osteoporosis | Study | Taiwan Health | Xgeva